Hypersensitivity Reactions to the GLP-1 Receptor Agonists Liraglutide and Semaglutide: A Case Series

被引：0
|
作者：
Barroso, B. [1 ,2 ,3 ]
Gomez-Lopez, A. [1 ]
Valverde-Monge, M. [1 ,2 ]
Betancor, D. [1 ,2 ]
de las Heras, M. [1 ]
Sastre, J. [1 ,2 ]
机构：
[1] Hosp Univ Fdn Jimenez Diaz, Allergy Unit, Madrid, Spain
[2] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain
[3] Hosp Univ Fdn Jimenez Diaz, Ave Reyes Catolicos 2, Madrid 28040, Spain
来源：
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2024年 / 34卷 / 02期
关键词：
GLP-1 receptor agonists; Liraglutide; Semaglutide; Allergy; Hypersensitivity;
D O I：
10.18176/jiaci.0932
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：133 / 135
页数：3
相关论文
共 50 条
  • [31] Adverse drug reactions of GLP-1 agonists: A systematic review of case reports
    Shetty, Rashmi
    Basheer, Fathima Thashreefa
    Poojari, Pooja Gopal
    Thunga, Girish
    Chandran, Viji Pulikkel
    Acharya, Leelavathi D.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (03)
  • [32] Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
    Liu, Qiyuan Keith
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [33] The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
    Silvia Tempia Valenta
    Alba Nicastri
    Federica Perazza
    Federica Marcolini
    Valentina Beghelli
    Anna Rita Atti
    Maria Letizia Petroni
    Current Treatment Options in Psychiatry, 2024, 11 (4) : 310 - 357
  • [34] GLP-1 RECEPTOR VARIANTS MARKEDLY DIFFERENTIATE GLYCAEMIC RESPONSE TO GLP-1 RECEPTOR AGONISTS: A DIRECT STUDY
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. -G
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 13 - 14
  • [35] GLP-1 receptor variants markedly differentiate glycaemic response to GLP-1 receptor agonists: a DIRECT study
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. G.
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I.
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    DIABETOLOGIA, 2017, 60 : S393 - S393
  • [36] The Effect of GLP-1 Receptor Agonists on Bowel Preparation
    Mahmood, Sabah
    Ozminkowski, Erin
    Sakiri, Ahmet
    Aqeel, Ammar
    Abbasi, Abu Fahad
    Andersen, William
    Zhan, Weihai
    Khan, Naser
    Hamoudah, Thayer
    Dawood, Altaf
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S360 - S361
  • [37] GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
    Bezin, Julien
    Gouverneur, Amandine
    Penichon, Marine
    Mathieu, Clement
    Garrel, Renaud
    Hillaire-Buys, Dominique
    Pariente, Antoine
    Faillie, Jean-Luc
    DIABETES CARE, 2023, 46 (02) : 384 - 390
  • [38] Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists
    Alhiary, Rasha
    Kesselheim, Aaron S.
    Gabriele, Sarah
    Beall, Reed F.
    Tu, S. Sean
    Feldman, William B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (07): : 650 - 657
  • [39] Mapping the effectiveness and risks of GLP-1 receptor agonists
    Xie, Yan
    Choi, Taeyoung
    Al-Aly, Ziyad
    NATURE MEDICINE, 2025, : 1038 - 1038
  • [40] Why are GLP-1 receptor agonists in short supply?
    Bailey, Clifford J.
    BRITISH JOURNAL OF DIABETES, 2022, 22 (02): : 72 - 72
12345